Literature DB >> 10815004

Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation.

K Abe1, H Saito.   

Abstract

Crocus sativus L., commonly known as saffron, is used in folk medicine for various purposes. Modern pharmacological studies have demonstrated that saffron extracts have antitumour effects, radical scavenger properties or hypolipaemic effects. Among the constituents of saffron extract, crocetin is mainly responsible for these pharmacological activities. In addition, recent behavioural and electrophysiological studies have demonstrated that saffron extract affects learning and memory in experimental animals. Saffron extract improved ethanol-induced impairments of learning behaviours in mice, and prevented ethanol-induced inhibition of hippocampal long-term potentiation, a form of activity-dependent synaptic plasticity that may underly learning and memory. This effect of saffron extract is attributed to crocin (crocetin di-gentiobiose ester), but not crocetin. Saffron extract or its active constituents, crocetin and crocin, could be useful as a treatment for neurodegenerative disorders accompanying memory impairment. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815004     DOI: 10.1002/(sici)1099-1573(200005)14:3<149::aid-ptr665>3.0.co;2-5

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  55 in total

Review 1.  The protective effects of crocin in the management of neurodegenerative diseases: a review.

Authors:  Tahereh Farkhondeh; Saeed Samarghandian; Hanieh Shaterzadeh Yazdi; Fariborz Samini
Journal:  Am J Neurodegener Dis       Date:  2018-02-05

Review 2.  Crocetin: an agent derived from saffron for prevention and therapy for cancer.

Authors:  William G Gutheil; Gregory Reed; Amitabha Ray; Shrikant Anant; Animesh Dhar
Journal:  Curr Pharm Biotechnol       Date:  2012-01       Impact factor: 2.837

3.  Crocus sativus L.: A comprehensive review.

Authors:  R Srivastava; H Ahmed; R K Dixit; S A Saraf
Journal:  Pharmacogn Rev       Date:  2010-07

Review 4.  Role of Herbal Medicines in the Management of Brain Injury.

Authors:  Mohammad Reza Safdari; Farzaneh Shakeri; Ameneh Mohammadi; Bahram Bibak; Peiman Alesheikh; Tannaz Jamialahmadi; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Authors:  Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh Togha; Hamed Cheraghmakani; Soodeh Razeghi; Seyyed Shamssedin Hejazi; Mohammad Hossein Yousefi; Roozbeh Alimardani; Amirhossein Jamshidi; Shams-Ali Rezazadeh; Aboulghasem Yousefi; Farhad Zare; Atbin Moradi; Ardalan Vossoughi
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

6.  Antidepressant properties of bioactive fractions from the extract of Crocus sativus L.

Authors:  Yang Wang; Ting Han; Yu Zhu; Cheng-Jian Zheng; Qian-Liang Ming; Khalid Rahman; Lu-Ping Qin
Journal:  J Nat Med       Date:  2009-09-29       Impact factor: 2.343

7.  Antilithiatic effects of crocin on ethylene glycol-induced lithiasis in rats.

Authors:  Fatemeh Abbasi Ghaeni; Bahareh Amin; Alireza Timcheh Hariri; Naser Tayyebi Meybodi; Hossein Hosseinzadeh
Journal:  Urolithiasis       Date:  2014-08-31       Impact factor: 3.436

8.  New minor glycoside components from saffron.

Authors:  Nguyen Huu Tung; Yukihiro Shoyama
Journal:  J Nat Med       Date:  2012-11-21       Impact factor: 2.343

Review 9.  Novel Neuroprotective Potential of Crocin in Neurodegenerative Disorders: An Illustrated Mechanistic Review.

Authors:  Sareh Kermanshahi; Ghazal Ghanavati; Mobina Abbasi-Mesrabadi; Mina Gholami; Luis Ulloa; Majid Motaghinejad; Sepideh Safari
Journal:  Neurochem Res       Date:  2020-09-17       Impact factor: 3.996

Review 10.  Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment.

Authors:  Grazia D'Onofrio; Seyed Mohammad Nabavi; Daniele Sancarlo; Antonio Greco; Stefano Pieretti
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.